在心力衰竭中,β2-上腺素受体的再分配会改变cAMP分区
Viacheslav O Nikolaev1, Alexey Moshkov, Alexander R Lyon
1Department of Cardiac Medicine, National Heart and Lung Institute, Imperial College London, Dovehouse Street, London SW3 6LY, UK.
Science (New York, N.Y.)
|February 27, 2010
概括
心脏细胞中的β-上腺素受体 (β-ARs) 控制心脏功能. 在心力衰竭中,β2ARs移动,改变循环腺单酸盐 (cAMP) 信号,并可能使病情恶化.
科学领域:
- 心脏病学 心脏病学
- 分子细胞生物学分子细胞生物学
- 生物物理学的生物物理.
背景情况:
- β1-和β2-上腺素受体 (βARs) 通过循环腺单酸盐 (cAMP) 调节心肌细胞功能和心力衰竭的发展.
- 贝塔AR在心肌细胞内的确切的空间定位和功能意义在很大程度上仍未确定.
- 贝塔AR与异构三元氨酸核酸结合蛋白 (G蛋白) 相结合.
研究的目的:
- 研究心肌细胞中β1和β2上腺体受体 (βARs) 的空间分布.
- 阐明betaAR定位对循环腺单酸盐 (cAMP) 信号传输的功能影响.
- 在慢性心力衰竭模型中检查βAR局部化和cAMP信号的变化.
主要方法:
- 使用纳米级活细胞扫描离子导电显微镜.
- 采用光共振能量转移 (FRET) 显微镜.
- 研究了健康成年老鼠和小鼠的心肌细胞,以及慢性心力衰竭的老鼠模型.
主要成果:
- 在健康的心肌细胞中,β2AR诱导的cAMP信号仅限于深层横管道,而β1AR则分布广泛.
- 在心力衰竭模型心肌细胞中,β2AR从横向管道重新分布到细胞顶部.
- 这种重新分配导致了分散的,而不是局部的,受体介导的cAMP信号.
结论:
- 贝塔ARs的空间定位对于心肌细胞中分隔的cAMP信号传递至关重要.
- 在心力衰竭中β2ARs的重新分配改变了cAMP的分区.
- 改变β2AR局部化和cAMP信号可能会导致心肌表型衰竭.
相关概念视频
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:26Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
01:22Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
01:17Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:26Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...